Albany, NY -- (ReleaseWire) -- 01/23/2014 -- This updated TMR report provides an overview of advanced "Treatments For Neurodegenerative Disorders" Neurodegenerative disorders cause progressive loss of function structure of the neurons in the human brain. The most commonly known neurodegenerative diseases are Alzheimer’s, Parkinson’s, Amyotrophic lateral sclerosis, and Huntington’s Syndrome. Most neurodegenerative disorders are caused because of genetic mutation in completely unrelated cells.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/neurodegenerative-disorders.html
Increase in the awareness regarding mental disorders and the rise in research and development regarding the treatment of such disorders are the major factors that are driving the growth of this market. However, despite large scale advancement in research in this field, there is a lack of complete curative treatment measures due to the manifold nature of the diseases. Moreover, many of the drugs presently available are for the treatment of symptoms of such diseases.
The market for neurodegenerative diseases can be categorized into major segments namely, progressive dementia, dementia with other neurological abnormalities and movement disorders. Out of these segments, the largest market share is occupied by progressive dementia followed by dementia with other neurological abnormalities. The major diseases segmented under neurodegenerative disorders are Huntington’s disease, Alzheimer’s disease, Pick’s disease, corticobasal ganglionic degeneration, Lewy body dementia, progressive supranuclear palsy, Hallervorden-Spatz disease, and multiple system atrophy.
Geographically, this market can be classified as North American, European, Asia Pacific, and the Rest of the World market. The major players in the neurodegenerative disorders market are Abbott Laboratories, Acorda Therapeutics, Inc., Baxter International, Inc., Boehringer Ingelheim Ltd., Cipla Ltd., Cellzome AG, Colucid Pharmaceuticals, Inc., Daiichi Sankyo Co. Ltd., Glenmark Generics Ltd., Neuro-Hitech, Inc., Roche Holding Ltd. and others.
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Read More Reports On Pharmaceutical Markets: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
90 State Street,
Albany NY - 12207
Browse Market Research Blog: